Search for: "C Lillie" Results 181 - 200 of 444
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2015, 3:51 am
| Plant variety in Case C‑242/14 | US Supreme Court on spiderman patent | Hospira v Genentech saga | Are EU policy-makers fighting the right copyright battles? [read post]
7 Jul 2015, 1:55 pm
Indianapolis, Indiana - In conjunction with non-Indiana co-counsel, an Indiana patent attorney for Eli Lilly and Company, Eli Lilly Export S.A. [read post]
6 Jul 2015, 12:36 pm
* Benna, Bnina, Baina: a carefully-scripted ruling from the CJEU Case C 147/14 Loutfi Management Propriété intellectuelle SARL v AMJ Meatproducts NV, Halalsupply NV is a Court of Justice of the European Union (CJEU) ruling regarding trade marks containing both Arabic and Latin letters. [read post]
2 Jul 2015, 4:00 am by Alan Macek
Some additional amendments to the Copyright Act relating to access to works for people with disabilities were introduced in Bill C-65 in June. [read post]
28 Jun 2015, 5:34 am
Claim 1 of the patent in suit (as amended in earlier proceedings) reads:A method of preparing a light stabilized antimicrobial material, characterised in that the method comprises the steps of:(a) preparing a solution comprising anorganic solvent and a source of silver in a quantity sufficient to provide a desired silver concentration in said material;(b) subjecting a material which includes gel-forming fibres containing one or more hydrophilic, amphoteric or anionic polymers to said solution for a… [read post]
26 Jun 2015, 4:10 am
 Writes Nick:The CJEU proceedings in Case C-34/10 concerned the German national patent. [read post]
9 Jun 2015, 1:06 pm
For example, after reviewing several studies, Professor Peter C. [read post]
26 May 2015, 2:50 pm by nedaj
Under Rules 2-01(b) and (c) of Regulation S-X, an auditor is considered not to be “independent” if, at any time during the engagement, the auditor provides prohibited non-auditor services to the client, such as bookkeeping or financial statement preparation services. [read post]
26 May 2015, 2:50 pm by nedaj
Under Rules 2-01(b) and (c) of Regulation S-X, an auditor is considered not to be “independent” if, at any time during the engagement, the auditor provides prohibited non-auditor services to the client, such as bookkeeping or financial statement preparation services. [read post]
26 May 2015, 12:53 pm
This patent covers a method of using Effient products for which Lilly claims an exclusively license. [read post]
26 May 2015, 7:42 am
  The ideal defendant’s case might occur in several ways:  similar biomarker evidence would point a finger at a purely genetic cause or at some other (perhaps voluntary or non-anthropogenic) exposure; or, a person exposed to a toxin known to cause the person's disease in susceptible people might have a gene that completely neutralized the toxic effect and also might lack a biomarker that is uniformly found in people whose disease was caused by exposure.Steve C. [read post]
13 May 2015, 4:00 am by Administrator
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
15 Jan 2015, 12:17 pm by Lawrence B. Ebert
Michael William McConnell of Kirkland & Ellis LLP, arguing on behalf of plaintiffs-appellees Bard and Goldfarb, won an affirmance of a District of Arizona finding of willfulnessin patent infringement. [ BARD PERIPHERAL VASCULAR v. [read post]